Senior Medical Director, IP&C, Professor
Children's Hospital of Philadelphia
Philadelphia, PA, United States
Dr. Ericka Hayes is a Professor in the Division of Pediatric Infectious Diseases at the University of Pennsylvania Perelman School of Medicine and the Children’s Hospital of Philadelphia. She serves as Senior Medical Director of Infection Prevention and Control.
A native of Mississippi, Dr. Hayes completed a B.S. in Chemical Engineering as well as her M.D. at Washington University. She completed her pediatrics residency training at the University of California, San Francisco. She returned to WU School of Medicine and Saint Louis Children;s Hospital for fellowship training in pediatric infectious diseases.
In 2005, she joined the Department of Pediatrics at WU School of Medicine/ Saint Louis Children's Hospital as faculty and served as the medical director of the Washington University Pediatric and Adolescent HIV program for 13 years as well as medical director of infection prevention from 2015 to 2022. She joined the faculty at Penn/CHOP in 2022.
Dr. Hayes’s other passions include medical education and pediatric global health. She was the co-course director of the preclinical pediatrics course at WU School of Medicine and was co-chair of the pediatric infectious diseases fellowship education committee for 14 years. She was a visiting lecturer in the department of pediatrics at the University of Malawi at Queen Elizabeth Central Hospital in Blantyre, Malawi from 2008-2010. She was also the Principal Investigator for the Summer Pediatric Research in Global Health Translation (SPRIGHT) Program from 2016-2022, a funded education initiative through the WU Children’s Discovery Institute that recruits and mentors summer undergraduate and graduate students to do public, international and translational research with a goal of fostering the development of future researchers who want to improve global child health.
Disclosure(s): No financial relationships to disclose
Wednesday, October 16, 2024
1:30 PM – 3:15 PM US PT
24 - Contact isolation should be used for patients with CTX-R/ESBL producing Enterobacterales
Wednesday, October 16, 2024
2:05 PM – 2:20 PM US PT